Qilian International Holding Group Limited (NASDAQ:QLI) Sees Large Growth in Short Interest

Qilian International Holding Group Limited (NASDAQ:QLI) was the target of a significant growth in short interest in March. As of March 15th, there was short interest totalling 64,600 shares, a growth of 509.4% from the February 29th total of 10,600 shares. Based on an average daily volume of 36,500 shares, the days-to-cover ratio is currently 1.8 days. Approximately 0.8% of the shares of the stock are sold short.

Qilian International Holding Group Stock Up 13.1 %

Shares of QLI traded up $0.08 during trading hours on Thursday, reaching $0.69. 1,823,750 shares of the stock traded hands, compared to its average volume of 74,242. The company’s 50-day moving average price is $0.57 and its two-hundred day moving average price is $0.58. Qilian International Holding Group has a 52-week low of $0.36 and a 52-week high of $1.35.

About Qilian International Holding Group

Qilian International Holding Group Limited manufactures and distributes active pharmaceutical ingredients (APIs), traditional Chinese medicine derivatives (TCMD), and other by-products in China. The company provides licorice products, including Gan Di Xin, an antitussive and expectorant medicine; Qilian Shan Licorice Extract, an ingredient for pharmaceutical companies to manufacture traditional licorice tablets; and Qilian Shan licorice liquid extract, a primary ingredient for medical preparation companies to produce compound licorice oral solutions.